Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg

Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg
LINALIGLIP M 5/500  are two commonly prescribed medications used in the treatment of type 2 diabetes. Let's break down what each medication does:
Linagliptin 5mg: Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones such as GLP-1. These hormones help regulate blood sugar levels by increasing insulin secretion and decreasing glucagon release from the pancreas. Linagliptin is typically taken once a day and is used to improve glycemic control in people with type 2 diabetes. The 5mg dosage refers to the strength of the medication.
Metformin Hydrochloride (SR) 500mg: Metformin is a biguanide medication that helps lower blood sugar levels by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues like muscle cells. The "SR" in the medication name stands for "sustained-release," which means the medication is formulated to release slowly over time, allowing for extended blood sugar control. The 500mg dosage refers to the strength of the medication.
It's not uncommon for healthcare providers to prescribe a combination of medications to address different aspects of diabetes management. The combination of LINALIGLIP M 5/500  can be effective in helping control blood sugar levels through different mechanisms:
Linagliptin helps by increasing the effects of GLP-1, which enhances insulin secretion and reduces glucagon release.
Metformin (sustained-release) works to improve insulin sensitivity and reduce glucose production in the liver.
For further information please contact:
contact@sterispharma.com
Order Now - https://www.sterisonline.com/product/linaliglip-m-5-500-134301